Skip to content

13F-HR filed by Finepoint Capital LP

Finepoint Capital LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 15:22:06 UTC, with 10 holding rows worth $2,707,993,215.

Accession
0000904454-26-000611
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 10 entries on the cover page, a total value of $2,707,993,215 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,707,993,215 with VALUE read as dollars as filed, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,290,300$984,021,489dollars as filedput
Amazon.com, Inc023135106COM2,128,300$530,265,945dollars as filedcall
INVESCO QQQ TR46090E103COM634,755$469,572,706dollars as filedput
iShares Russell 2000 ETF464287655SHS1,472,000$409,054,080dollars as filedput
QXO INC COM NEW82846H405Stock23,356,193$273,033,896dollars as filed
RXO, Inc.74982T103Common Stock, $0.01 par value2,042,751$41,794,685dollars as filed
ALEANNA INC01444V111*W EXP 12/13/202490,000$153,860dollars as filed
ALEANNA INC01444V103COM CL A27,717$73,034dollars as filed
MONEYHERO LIMITEDG6202B119*W EXP 09/13/202895,000$23,449dollars as filed
Calidi Biotherapeutics Inc320703507COM66$71dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-26-000611this filing2026-11-13